Feedback
ASTRAZEN 
Reputation: 642,729 • Aug 23, 2022 10:11 AM
Novavax's protein-based jab offers better immunity against new variants: CEO Stanley Erck
Novavax's protein-based vaccine was approved for emergency use by the US Food and Drug Administration (USFDA) last month in India.
The Economic Times
Vote
Comment
Share
NSE:ASTRAZEN price when posted: 3,033.8